In today's New York Times is an article by Katie Thomas called "Breaking the Seal on Drug Research," concerning recent efforts of academic researchers and activists working to make clinical drug trial data public. "More researchers are insisting on seeing all the data behind all clinical trials for drugs, not just the rosy reports that companies choose to release."
Remind you of anything on going on in the world of public relations and social media measurement?
We might not think of members of the standards-setting groups the Coalition and the Conclave as activists, but their work to make measurement more transparent (see especially The Sources and Methods Transparency Table) is a similar effort. If publication bias (the selective publication of research results) and other results-skewing problems are rife in medical research, then there's little doubt our world of public relations research can use some tidying up as well.
Or, as the Times' article states: "Until recently, the idea that companies should routinely hand over detailed data about their clinical trials might have sounded far-fetched. Now, the onus is on the industry to explain why it shouldn’t." This kind of transparency means progress for the measurement industry, and for that we have the current standards-setting movement to thank. -- Bill Paarlberg, editor
(Thanks to socialsquare for the image.)
Bill Paarlberg, Editor of The Measurement Standard, has been writing about public relations measurement for 20 years. He is editor of the award-winning "Measuring the Networked Nonprofit" by Beth Kanter and Katie Paine, and editor of two other books on measurement by Katie Paine, "Measure What Matters" and "Measuring Public Relationships." Visit Bill Paarlberg's page on LinkedIn.
The Measurement Standard is a publication of News Group International.